A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for source information, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust market exists on messaging services, where communities with numerous of members share “before and after” images, injection guides and assertions of next-day British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Express Worries
Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in users injecting substances of uncertain source.
Several professionals stated the popularity for retatrutide could be connected to the rising cost of licensed slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, risking fines, prosecution or imprisonment.
Service Response and Material Elimination
Based on TikTok, the platform has taken down problematic material and prohibited associated hashtags and query recommendations. The company stated it was committed to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Trading Operations
Research also discovered communities with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, populated with photos of slimming results, positive reviews and detailed guides for mixing or injecting at home.
Within moments of entering one group, a seller posted contact information, where the majority of purchases occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, medical conditions or previous experience.
Product Details and Pricing
Inside these groups, posts display dark colored parcels with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how much time a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for Telegram said it actively monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting substances they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are using social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her team has already encountered individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may expose users to potentially significant health risks”.
